.

.


The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract.
    Letters in applied microbiology (Lett Appl Microbiol ) Vol: 26 Issue 5 Pages: 333-7
    Pub: 1998 May Epub:
    • Charteris WP
    • Kelly PM
    • Morelli L
    • Collins JK

  2. Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.
    Thorax (Thorax ) Vol: 72 Issue 1 Pages: 13-22
    Pub: 2017 Jan Epub: 2016 Aug 2
    • Segal LN
    • Clemente JC
    • Wu BG
    • Wikoff WR
    • Gao Z
    • Li Y
    • Ko JP
    • Rom WN
    • Blaser MJ
    • Weiden MD

  3. Metronidazole: in vitro activity, pharmacology and efficacy in anaerobic bacterial infections.
    Pharmacotherapy (Pharmacotherapy ) Vol: 1 Issue 1 Pages: 28-38
    Pub: 1981 Jul-Aug Epub:
    • Tally FP
    • Sullivan CE

  4. In vitro susceptibility of anaerobic bacteria to nitroimidazoles.
    Scandinavian journal of infectious diseases. Supplementum (Scand J Infect Dis Suppl ) Vol: 26 Issue Pages: 42-5
    Pub: 1981 Epub:
    • Olsson-Liljequist B
    • Nord CE

  5. [Relationship between the sensitivity of Pseudomonas aeruginosa and the post-antibiotic effect of sparfloxacin and ciprofloxacin].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia (Rev Esp Quimioter ) Vol: 11 Issue 4 Pages: 333-8
    Pub: 1998 Dec Epub:
    • Pastor A
    • Cantón E
    • Pemán J

  6. Bacteriologic profile and antibiogram of blood culture isolates from a children`s hospital in Kabul.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP (J Coll Physicians Surg Pak ) Vol: 24 Issue 6 Pages: 396-399
    Pub: 2014 Jun Epub:
    • Tariq TM

  7. Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002).
    Annals of clinical microbiology and antimicrobials (Ann Clin Microbiol Antimicrob ) Vol: 3 Issue Pages: 14
    Pub: 2004 Jul 29 Epub: 2004 Jul 29
    • Jones ME
    • Draghi DC
    • Thornsberry C
    • Karlowsky JA
    • Sahm DF
    • Wenzel RP

  8. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
    Journal of hepatology (J Hepatol ) Vol: 60 Issue 4 Pages: 824-31
    Pub: 2014 Apr Epub: 2013 Dec 6
    • Vrieze A
    • Out C
    • Fuentes S
    • Jonker L
    • Reuling I
    • Kootte RS
    • van Nood E
    • Holleman F
    • Knaapen M
    • Romijn JA
    • Soeters MR
    • Blaak EE
    • Dallinga-Thie GM
    • Reijnders D
    • Ackermans MT
    • Serlie MJ
    • Knop FK
    • Holst JJ
    • van der Ley C
    • Kema IP
    • Zoetendal EG
    • de Vos WM
    • Hoekstra JB
    • Stroes ES
    • Groen AK
    • Nieuwdorp M

  9. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
    International journal of food microbiology (Int J Food Microbiol ) Vol: 98 Issue 2 Pages: 211-7
    Pub: 2005 Feb 1 Epub:
    • Zhou JS
    • Pillidge CJ
    • Gopal PK
    • Gill HS

  10. Short- and long-term effects of oral vancomycin on the human intestinal microbiota.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 72 Issue 1 Pages: 128-136
    Pub: 2017 Jan Epub: 2016 Oct 5
    • Isaac S
    • Scher JU
    • Djukovic A
    • Jiménez N
    • Littman DR
    • Abramson SB
    • Pamer EG
    • Ubeda C

Full list available by paid subscriptions

For More information see this summary.